Emergent announces OTC access to Narcan Nasal Spray for opioid emergency
According to Emergent BioSolutions, the expanded access will give people the ability to respond in an opioid emergency,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
31 Aug 23
According to Emergent BioSolutions, the expanded access will give people the ability to respond in an opioid emergency,…
31 Aug 23
In the U.S., ROCTAVIAN Now Commercially Available and Hemophilia Treatment Centers Have Begun Screening Eligible Individuals
30 Aug 23
Ginkgo will develop large language models (LLMs) for genomics, protein function, and synthetic biology on Google Cloud's Vertex…
30 Aug 23
The anti-cancer injection, which takes around seven minutes to administer, has received approval from the Medicines and Healthcare…
30 Aug 23
The partnership is intended to study the anti-inflammatory and anti-fibrotic potential of the life sciences company’s RSBT-001 in…
29 Aug 23
The approval was based on the findings from the Phase 3 COMMANDS trial in which 58.5% of patients…
29 Aug 23
Mycamine is said to be a preferred treatment in hospitals and intensive care units around the world for…
29 Aug 23
Upon completion of the transaction, Thorne will transition into a privately held entity, and its common stock shares…
29 Aug 23
Submissions are supported by two Phase 3 clinical trials demonstrating risankizumab achieved the primary endpoint of clinical remission…
29 Aug 23
Centene to sell Circle Health Group to Pure Health at an enterprise value of approximately $1.2B